CYP2E1基因Rsa Ι/Pst Ι多态性与肺癌易感性：一项涉及10947名受试者的荟萃分析。
CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: A meta-analysis involving 10,947 subjects.
作者信息
Shen Ze-Tian, Wu Xin-Hu, Li Bing, Shen Jun-Shu, Wang Zhen, Li Jing, Zhu Xi-Xu
机构信息
Department of Radiation Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
出版信息
J Cell Mol Med. 2018 Jul;22(7):3703. doi: 10.1111/jcmm.13668. Epub 2018 May 29.
The above article, published in the Journal of Cellular and Molecular Medicine on 14 September 2016 in Wiley Online Library (wileyonlinelibrary.com), and in Volume 19, pp. 2136-2142, has been retracted by agreement between the authors, the journal Editor in Chief, Stefan Constantinescu, and John Wiley & Sons Ltd. The retraction has been agreed due to unattributed overlap of the language used in the "Materials and method" and "Discussion" sections of this study and the following article published in Lung Cancer: "CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians" by Ping Zhan, Jing Wang, Yu Zhang, Li-Xin Qiu, Su-feng Zhao, Qian Qian, Shu-Zhen Wei, Li-Ke Yu and Yong Song, Volume 69, 2010, pages 19-25. REFERENCE Shen Z-T, Wu X-H, Li B, Shen J-S, Wang Z, Li J, Zhu X-X. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects. J Cell Mol Med. 2015;19:2136-2142. https://doi.org/10.1111/jcmm.12579.
上述文章发表于《细胞与分子医学杂志》，2016年9月14日刊登在Wiley Online Library（wileyonlinelibrary.com）上，卷号为19，页码为2136 - 2142，经作者、期刊主编斯特凡·康斯坦丁内斯库以及约翰·威利父子有限公司协商一致后予以撤回。撤回原因是本研究“材料与方法”及“讨论”部分使用的语言与以下发表于《肺癌》杂志的文章存在未注明出处的重叠：Ping Zhan、Jing Wang、Yu Zhang、Li-Xin Qiu、Su-feng Zhao、Qian Qian、Shu-Zhen Wei、Li-Ke Yu和Yong Song所著的“CYP2E1 Rsa I/Pst I多态性与亚洲人肺癌风险相关”，发表于2010年第69卷，第19 - 25页。参考文献：Shen Z-T, Wu X-H, Li B, Shen J-S, Wang Z, Li J, Zhu X-X. CYP2E1 Rsa Ι/Pst Ι多态性与肺癌易感性：一项纳入10947名受试者的荟萃分析。《细胞与分子医学杂志》。2015年；19：2136 - 2142。https://doi.org/10.1111/jcmm.12579 。
Zotero 插件